Prediction of imminent fracture risk in Canadian women and men aged 45 years or older: external validation of the Fracture Risk Evaluation Model (FREM)

[1]  M. Javaid,et al.  Predicting Imminent Fractures in Patients With a Recent Fracture or Starting Oral Bisphosphonate Therapy: Development and International Validation of Prognostic Models , 2021, Journal of bone and mineral research : the official journal of the American Society for Bone and Mineral Research.

[2]  J. Kanis,et al.  SCOPE 2021: a new scorecard for osteoporosis in Europe , 2021, Archives of Osteoporosis.

[3]  S. Möller,et al.  Validation of the fracture risk evaluation model (FREM) in predicting major osteoporotic fractures and hip fractures using administrative health data. , 2021, Bone.

[4]  J. Kanis,et al.  The use of 2-, 5-, and 10-year probabilities to characterize fracture risk after a recent sentinel fracture , 2020, Osteoporosis International.

[5]  Angshu Rai,et al.  Deep Learning With Electronic Health Records for Short-Term Fracture Risk Identification: Crystal Bone Algorithm Development and Validation , 2020, Journal of Medical Internet Research.

[6]  J. Kanis,et al.  Adjusting conventional FRAX estimates of fracture probability according to the recency of sentinel fractures , 2020, Osteoporosis International.

[7]  C. Cooper,et al.  Secular trends in the initiation of therapy in secondary fracture prevention in Europe: a multi-national cohort study including data from Denmark, Catalonia, and the United Kingdom , 2020, Osteoporosis International.

[8]  R. Barron,et al.  Validated prediction of imminent risk of fracture for older adults. , 2020, The American journal of managed care.

[9]  J. Kanis,et al.  Measured height loss predicts incident clinical fractures independently from FRAX: a registry-based cohort study , 2020, Osteoporosis International.

[10]  L. Lix,et al.  Development of an administrative definition for celiac disease , 2019, BMC Research Notes.

[11]  S. A. Jackson,et al.  Predictors of imminent non-vertebral fracture in elderly women with osteoporosis, low bone mass, or a history of fracture, based on data from the population-based Canadian Multicentre Osteoporosis Study (CaMos) , 2019, Archives of Osteoporosis.

[12]  P. Vestergaard,et al.  Hip fracture rates and time trends in use of anti-osteoporosis medications in Denmark for the period 2005 to 2015: Missed opportunities in fracture prevention. , 2019, Bone.

[13]  The Lancet Diabetes & Endocrinology.  Osteoporosis: a roadmap to close the treatment gap. , 2018, The lancet. Diabetes & endocrinology.

[14]  Kenneth H. Rubin,et al.  A New Fracture Risk Assessment Tool (FREM) Based on Public Health Registries , 2018, Journal of bone and mineral research : the official journal of the American Society for Bone and Mineral Research.

[15]  C. Becker,et al.  Development of a risk assessment tool for osteoporotic fracture prevention: A claims data approach. , 2018, Bone.

[16]  G. Oster,et al.  Predictors of near-term fracture in osteoporotic women aged ≥65 years, based on data from the study of osteoporotic fractures , 2017, Osteoporosis International.

[17]  C. Cooper,et al.  Identification and management of patients at increased risk of osteoporotic fracture: outcomes of an ESCEO expert consensus meeting , 2017, Osteoporosis International.

[18]  V. Gudnason,et al.  Imminent risk of fracture after fracture , 2017, Osteoporosis International.

[19]  C. Roux,et al.  Imminent fracture risk , 2017, Osteoporosis International.

[20]  C. Cooper,et al.  Mind the (treatment) gap: a global perspective on current and future strategies for prevention of fragility fractures , 2017, Osteoporosis International.

[21]  Nicholas Harvey,et al.  The Osteoporosis Treatment Gap , 2014, Journal of bone and mineral research : the official journal of the American Society for Bone and Mineral Research.

[22]  C. Cooper,et al.  Osteoporosis in the European Union: a compendium of country-specific reports , 2013, Archives of Osteoporosis.

[23]  M. Bech,et al.  Comparison of different screening tools (FRAX®, OST, ORAI, OSIRIS, SCORE and age alone) to identify women with increased risk of fracture. A population-based prospective study. , 2013, Bone.

[24]  Kim Brixen,et al.  Risk assessment tools to identify women with increased risk of osteoporotic fracture: Complexity or simplicity? A systematic review , 2013, Journal of bone and mineral research : the official journal of the American Society for Bone and Mineral Research.

[25]  L. Lix,et al.  Osteoporosis-related fracture case definitions for population-based administrative data , 2012, BMC Public Health.

[26]  J. Kanis,et al.  Pitfalls in the external validation of FRAX , 2012, Osteoporosis International.

[27]  L. Lix,et al.  Construction and validation of a simplified fracture risk assessment tool for Canadian women and men: results from the CaMos and Manitoba cohorts , 2011, Osteoporosis International.

[28]  W. Leslie,et al.  Fracture prediction and calibration of a Canadian FRAX® tool: a population-based report from CaMos , 2011, Osteoporosis International.

[29]  Eugene McCloskey,et al.  Independent clinical validation of a Canadian FRAX tool: Fracture prediction and model calibration , 2010, Journal of bone and mineral research : the official journal of the American Society for Bone and Mineral Research.

[30]  Carol Coupland,et al.  Predicting risk of osteoporotic fracture in men and women in England and Wales: prospective derivation and validation of QFractureScores , 2009, BMJ : British Medical Journal.

[31]  N. D. Nguyen,et al.  Development of prognostic nomograms for individualizing 5-year and 10-year fracture risks , 2008, Osteoporosis International.

[32]  O. Johnell,et al.  FRAX™ and the assessment of fracture probability in men and women from the UK , 2008, Osteoporosis International.

[33]  N. D. Nguyen,et al.  Development of a nomogram for individualizing hip fracture risk in men and women , 2007, Osteoporosis International.

[34]  D. Black,et al.  Clinical Practice. Postmenopausal Osteoporosis. , 2005, The New England journal of medicine.

[35]  W. Leslie,et al.  Construction and validation of a population-based bone densitometry database. , 2005, Journal of clinical densitometry : the official journal of the International Society for Clinical Densitometry.

[36]  W. Leslie,et al.  Establishing a regional bone density program: lessons from the Manitoba experience. , 2003, Journal of clinical densitometry : the official journal of the International Society for Clinical Densitometry.

[37]  A. Wajda,et al.  Incidence and Prevalence of Diabetes in Manitoba, 1986–1991 , 1996, Diabetes Care.

[38]  J. Hanley,et al.  A method of comparing the areas under receiver operating characteristic curves derived from the same cases. , 1983, Radiology.

[39]  L. Lix,et al.  Population-based data sources for chronic disease surveillance. , 2008, Chronic diseases in Canada.

[40]  Lisa M Lix,et al.  Effectiveness of bone density measurement for predicting osteoporotic fractures in clinical practice. , 2007, The Journal of clinical endocrinology and metabolism.

[41]  C. Rosen.  Clinical practice. Postmenopausal osteoporosis. , 2005, The New England journal of medicine.